What is Exelixis's free cash flow?

Exelixis (EXEL) reported free cash flow of $250.34M in Q1 2026.

How has Exelixis's free cash flow changed year-over-year?

Exelixis's free cash flow increased by 20.1% year-over-year, from $208.49M to $250.34M.

What is the long-term trend for Exelixis's free cash flow?

Over 4 years (2021 to 2025), Exelixis's free cash flow has grown at a 26.1% compound annual growth rate (CAGR), from $346.58M to $875.84M.

Exelixis EXEL Free cash flow

Free cash flow at other companies

Eli LillyLLY

$3.01B+1,828%

PfizerPFE

$2.18B+23.0%

Summit TherapeuticsSMMT

——

IncyteINCY

——

Ionis PharmaceuticalsIONS

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$610.8M+10.0%

Gross profit$590.9M+10.2%

Operating income$251.3M+34.5%

Net income$210.5M+31.9%

EPS (diluted)$0.79+43.6%

Balance sheet

See full

Cash & equivalents$226.2M+23.1%

Total debt$169.5M-9.4%

Total equity$1.9B-9.2%

Total assets$2.6B-8.6%

Cash flow

See full

Operating cash flow$251.8M+19.1%

CapEx$1.5M-48.9%

Valuation

See full

Market cap$13.05B+10.1%

Enterprise value$12.99B+9.5%

P/E15.7×-2.8×

P/S5.5×+0.3×

Profitability

See full

Gross margin96.4%-0.3pp

Operating margin39.4%+6.3pp

Net margin35.1%+7.1pp

FCF margin38.6%+2.9pp

Returns & leverage

See full

Return on equity41%+10.8pp

Debt / equity0.1×0.0×

Current ratio3.3×-0.2×

Where this comes from

Calculated from Exelixis’s reported figures.

$251.8Mnet cash from operating−$1.5Mcapital expenditures=$250.34M

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exelixis's free cash flow?: Exelixis (EXEL) reported free cash flow of $250.34M in Q1 2026.
How has Exelixis's free cash flow changed year-over-year?: Exelixis's free cash flow increased by 20.1% year-over-year, from $208.49M to $250.34M.
What is the long-term trend for Exelixis's free cash flow?: Over 4 years (2021 to 2025), Exelixis's free cash flow has grown at a 26.1% compound annual growth rate (CAGR), from $346.58M to $875.84M.